FDA Approves New Treatment for Pompe Disease | FDA News
For Immediate Release: August 06, 2021 Today, the U.S. Food and Drug Administration approved Nexviazyme (avalglucosidase alfa-ngpt) for intravenous infusion to treat patients 1 year of age and older with…